All In MedTech

FDA Clearance Tracker · P150048-S077

INSPIRIS RESILIA Aortic Valve, KONECT RESILIA Aortic Valve Conduit (AVC), MITRIS RESILIA Mitral Valve

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 16, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 16, 2024

Approved

Time to decision

61 days

Received Nov 16, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150048-S077
Device name
INSPIRIS RESILIA Aortic Valve, KONECT RESILIA Aortic Valve Conduit (AVC), MITRIS RESILIA Mitral Valve
Applicant location
Irvine, CA
Received
Nov 16, 2023
Decided
Jan 16, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150048

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

approval for a sterilization manufacturing site located at Steris Applied Sterilization Technologies (AST), Isomedix Operations, Inc., 43425 Business Park Drive Temecula, California 92590

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.